| Literature DB >> 32417846 |
Ping Huang1, Bingli Qi1, Hairong Yao1, Liang Zhang1, Yanying Li1, Qian Li1.
Abstract
BACKGROUND Ovarian cancer is one of the most common gynecological malignancies and mortality ranks the highest in cancer-associated death in females' worldwide. Here, we attempted to evaluate the effect of DANCR on the biological behavior of transforming growth factor-ß (TGF-ß) stimulated ovarian cancer cells. MATERIAL AND METHODS The expression of DANCR in ovarian cancer cells (A2780 and SKOV3) treated with TGF-ß were detected by quantitative real-time polymerase chain reaction (qRT-PCR). DANCR silencing was constructed using lentiviral transfection in ovarian cancer cells. The Cell Counting Kit-8 (CCK-8), flow cytometry and Transwell assays were performed to measure some cytology index. Western blot was utilized to explore the effect of DANCR on Krüppel-like factor 5 (KLF5) expression. RESULTS The expression of DANCR in cancer cells (A2780 and SKOV3) treated with TGF-ß was significantly higher. DANCR silencing suppressed cell viability, migration and invasion, and induced cell apoptosis of TGF-ß treated ovarian cancer cells. Bioinformatics analysis showed that DANCR served as a sponge for miR-214, and also showed that KLF5 was targeted by miR-214. In addition, DANCR could inhibit the expression of KLF5. CONCLUSIONS We are the first to report that knockdown of DANCR could affect the biological process of ovarian cancer cells treated with TGF-ß by sponging miR-214, which may provide new therapeutic ideas of ovarian cancer.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32417846 PMCID: PMC7251966 DOI: 10.12659/MSM.922760
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1(A–E) DANCR silencing suppressed cell viability, migration and invasion, and induced cell apoptosis of TGF-β treated ovarian cancer cells. (A) The expression of DANCR in cancer cells (A2780 and SKOV3) treated with TGF-β was obviously higher than that in untreated control cells. (B) DANCR silencing was established in A2780 and SKOV3 cells treated with TGF-β. (C) The CCK-8 assay showed knockdown of DANCR reduced the proliferation of TGF-β treated ovarian cancer cells obviously. (D) Flow cytometry analysis demonstrated DANCR silencing promoted a higher cell apoptosis percentage than that in the control group. * P<0.05 compared to control group; # P<0.05 compared to TGF-β group. TGF-β – transforming growth factor-β; CCK-8 – Cell Counting Kit-8.
Figure 2DANCR act as a sponge for miR-214. (A) Bioinformatics analysis showed that miR-214 has a potential binding site with DANCR. (B) MiR-214 mimic repressed the luciferase activity of only DANCR wild type in A2780 and SKOV3 cells. (C) MiR-214 expression was negatively correlated with DANCR expression in ovarian cancer cells. (D) MiR-214 expression level was notably downregulated in TGF-β treated ovarian cancer cells. (E) DANCR silencing could elevate miR-214 expression level significantly in A2780 and SKOV3 cells treated with TGF-β, which was reversed by miR-214 inhibitor. (F) MiR-214 inhibitor could abolish the suppression by si-DANCR. (G) MiR-214 inhibitor could increase the apoptosis rate of TGF-β treated 2 cell lines transfected with DANCR silencing. (H) MiR-214 inhibitor could rescue the suppression by si-DANCR in the migration and invasion number of 2 cells. * P<0.05 compared to control group. TGF-β – transforming growth factor-β.
Figure 3(A) KLF5 is targeted by miR-214 using TargetScan. (B) A highly conserved putative binding site was identified at KLF5 3′-UTR using TargetScan. (C) KLF5 mRNA expression was significantly increased in ovarian cancer cells treated with TGF-β. (D) MiR-214 mimic obviously suppressed KLF6 expression. * P<0.05 compared to control group. TGF-β – transforming growth factor-β.
Figure 4DANCR could suppress KLF5 expression. DANCR knockdown could suppress the expression level of KLF5 in TGF-β stimulated cancer cells, which was rescued by miR-214 inhibitor. * P<0.05 compared to control group. TGF-β – transforming growth factor-β.